Savastano Alfonso, Gambini Gloria, Carlà Matteo Mario, Caporossi Tomaso, Giannuzzi Federico, Rizzo Clara, Killian Raphael, Rizzo Stanislao
Ophthalmology Unit, "Fondazione Policlinico Universitario A. Gemelli IRCCS", Rome, Italy.
Catholic University "Sacro Cuore", Rome, Italy.
Eur J Ophthalmol. 2023 Nov;33(6):2303-2308. doi: 10.1177/11206721231188153. Epub 2023 Jul 12.
To describe the efficacy and safety of the adjustable system eyeWatch in vitrectomized glacomatous eyes.
Prospective, non-comparative, small case series of 2 patients who underwent glaucoma drainage device implant with the eyeWatch system. Intraocular pressure, number of medications and early and late complications were evaluated.
None of the operated eyes developed early or late complications. After 1 week post operatively, the IOP raised at 28 mmHg in the first eye and 25 mmHg in the second one. The eyeWatch Pen was used to open and set the device into position 3 (that means implant half opened) After waiting for 30 min, IOP was 15 mmHg and 11 mmHg, respectively. Thirty days after surgery we set the EyeWatch into position 0 (that means implant full opened) even though the IOP was under control. A new IOP measurement was done and we registered that IOP was 14 mmHg and 10 mmHg respectively, and it remained stable after six months of follow up.
In conclusion, in our case series the use of eyeWatch adjustable system allows a safe and gradual regulation of the flow during post-operative management also in vitrectomized eyes. Considering the percentage of hypotony related complications in vitrectomized eyes this system is an effective and safe technique to handle glaucoma in post vitreoretinal surgery eyes.
描述可调节系统eyeWatch在玻璃体切除术后青光眼眼中的疗效和安全性。
对2例行青光眼引流装置植入术并使用eyeWatch系统的患者进行前瞻性、非对照性小病例系列研究。评估眼压、用药数量以及早期和晚期并发症。
所有手术眼均未出现早期或晚期并发症。术后1周，第一只眼眼压升至28 mmHg，第二只眼升至25 mmHg。使用eyeWatch笔将装置打开并设置到位置3（即植入物半开）。等待30分钟后，眼压分别为15 mmHg和11 mmHg。术后30天，尽管眼压得到控制，我们仍将EyeWatch设置到位置0（即植入物完全打开）。进行了新的眼压测量，我们记录到眼压分别为14 mmHg和10 mmHg，并且在随访6个月后保持稳定。
总之，在我们的病例系列中，eyeWatch可调节系统的使用在玻璃体切除术后的管理中也能安全、逐步地调节房水引流，即使在玻璃体切除的眼中。考虑到玻璃体切除术后低眼压相关并发症的发生率，该系统是处理玻璃体视网膜手术后青光眼的一种有效且安全的技术。
